AB Science receives FDA and EMA authorization for phase 3 Trial of prostate cancer treatment
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
These medicines are essential in preventing RhD immunisation during pregnancy
Commercial production is expected to begin soon
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
The wholly owned subsidiary will carry on the business of all types of research and development and other related services
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
Lijo Chacko is the Chief Executive Officer – Middle East & Africa at Sigachi Industries
The facility will manufacture 13,200 MTPA Benzyl Chloride, 9,600 MTPA Benzyl Alcohol, and 7,200 MTPA Benzaldehyde
Subscribe To Our Newsletter & Stay Updated